Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EHAB 
Enhabit Inc. (EHAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/20/2025: EHAB (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.38
1 Year Target Price $9.38
| 1 | Strong Buy |
| 0 | Buy |
| 4 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -60.95% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 408.56M USD | Price to earnings Ratio - | 1Y Target Price 9.38 |
Price to earnings Ratio - | 1Y Target Price 9.38 | ||
Volume (30-day avg) 5 | Beta 1.31 | 52 Weeks Range 6.47 - 10.90 | Updated Date 10/19/2025 |
52 Weeks Range 6.47 - 10.90 | Updated Date 10/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.66 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -12.84% | Operating Margin (TTM) 6.28% |
Management Effectiveness
Return on Assets (TTM) 2.61% | Return on Equity (TTM) -20.37% |
Valuation
Trailing PE - | Forward PE 16.34 | Enterprise Value 905785190 | Price to Sales(TTM) 0.39 |
Enterprise Value 905785190 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 0.87 | Enterprise Value to EBITDA 14.43 | Shares Outstanding 50690382 | Shares Floating 40165538 |
Shares Outstanding 50690382 | Shares Floating 40165538 | ||
Percent Insiders 3.45 | Percent Institutions 103.1 |
Upturn AI SWOT
Enhabit Inc.
Company Overview
History and Background
Enhabit, Inc. spun off from Encompass Health Corp. in July 2022, becoming an independent publicly traded company. It focuses on providing home health and hospice services. It was formerly known as EHHI Holdings, Inc.
Core Business Areas
- Home Health: Provides a range of medical services in patients' homes, including skilled nursing, therapy, and personal care.
- Hospice: Offers end-of-life care, focusing on pain management, emotional support, and spiritual care for patients and their families.
Leadership and Structure
Barbara A. Jacobsmeyer serves as the CEO. The organizational structure includes operational teams focused on home health and hospice services, supported by corporate functions like finance, HR, and legal.
Top Products and Market Share
Key Offerings
- Skilled Nursing: Provides in-home skilled nursing care for patients recovering from surgery, managing chronic conditions, or requiring specialized medical attention. Market share is fragmented; Enhabit competes with national and regional players. Competitors: LHC Group (now part of Optum), Amedisys, and various regional providers. Unable to get definitive market share or revenue for this segment in isolation.
- Hospice Care: Offers comprehensive end-of-life care services, including pain management, emotional support, and spiritual guidance for patients and their families. Market share is also fragmented. Competitors: VITAS Healthcare (owned by Chemed Corp.), Amedisys, and regional hospice providers. Unable to get definitive market share or revenue for this segment in isolation.
Market Dynamics
Industry Overview
The home health and hospice industry is experiencing growth due to an aging population, increasing prevalence of chronic diseases, and a preference for in-home care. Technological advancements and regulatory changes also impact the industry.
Positioning
Enhabit is a significant player in the home health and hospice market, with a broad geographic footprint. Its competitive advantages include its established brand, experienced workforce, and comprehensive service offerings.
Total Addressable Market (TAM)
The TAM for home health and hospice care is estimated to be over $200 billion. Enhabit is positioned to capture a significant portion of this market due to its national presence and comprehensive service offerings.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Established network of care locations
- Experienced healthcare professionals
- Comprehensive service offerings
Weaknesses
- High dependence on government reimbursement
- Labor shortages in the healthcare industry
- Integration challenges post-spin-off
- Exposure to regulatory changes
Opportunities
- Expanding service offerings to include telehealth and remote monitoring
- Acquiring smaller regional providers
- Partnering with hospitals and health systems
- Increasing market penetration in underserved areas
Threats
- Changes in government reimbursement policies
- Increased competition from other home health and hospice providers
- Rising labor costs
- Potential for lawsuits related to patient care
Competitors and Market Share
Key Competitors
- LHCG
- AMED
- CHE
Competitive Landscape
Enhabit competes with large national providers, regional players, and local agencies. Its competitive advantage lies in its established brand and comprehensive service offerings. However, it faces challenges related to labor costs and regulatory changes.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to the performance of the home health and hospice segments within Encompass Health prior to the spin-off.
Future Projections: Analysts project revenue growth in the mid-single digits, driven by organic growth and potential acquisitions. Improving profitability is a key focus.
Recent Initiatives: Recent initiatives include focusing on operational efficiency, improving patient outcomes, and expanding telehealth capabilities.
Summary
Enhabit Inc. is a significant player in the growing home health and hospice market, benefiting from an aging population. The company faces challenges including regulatory hurdles and labor costs. Success hinges on improving operational efficiency, expanding service offerings, and navigating the evolving healthcare landscape. Financial data is still pending post spin-off to truly evaluate the company's strengths and weaknesses, it appears to be on a relatively solid foundation, but there are many threats and opportunities.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and based on publicly available data. Financial data is subject to change pending official releases.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Enhabit Inc.
Exchange NYSE | Headquaters Dallas, TX, United States | ||
IPO Launch date 2022-07-01 | President, CEO & Director Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 10600 | Website https://www.ehab.com |
Full time employees 10600 | Website https://www.ehab.com | ||
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.